Skip to content Skip to footer
A $19 price target, a potential once-yearly treatment and a modest-market-share thesis put EPRX in focus For biotechnology investors, the most compelling opportunities sometimes involve a familiar medicine delivered in an unfamiliar, and potentially more valuable, way. That is the investment case…
October 6, 2026 — Healthcare dealmaking, nuclear power and optical networking put tangible business catalysts behind some of the market’s biggest advances. Option Care Health (OPCH), Ciena (CIEN) and Constellation Energy (CEG) lead a compelling cross-sector rally in the supplied trading snapshot,…
Washington’s drive to strengthen domestic drone manufacturing is creating opportunities across aircraft, components, autonomous software and defense systems, and giving Wall Street more than one way to participate. America’s next industrial contest is taking place a few hundred feet above the ground,…